New CEO commentary: “Bridging Corona”

PHI’s strong financial position together with government initiatives are projected to bridge the financial effects of the COVID-19 pandemic well into 2021 with the current organization, if not all the way through 2021.

Read the commentary here.

For additional information, please contact:
Peter Egelberg

E-mail: ir@phiab.se
Web: www.phiab.com – Live cell imaging & analysis

Phase Holographic Imaging (PHI) leads the ground-breaking development of time-lapse cytometry instrumentation and software. With the first instrument introduced in 2011, the company today offers a range of products for long-term quantitative analysis of living cell dynamics that circumvent the drawbacks of traditional methods requiring toxic stains. Headquartered in Lund, Sweden, PHI trades through a network of international distributors. Committed to promoting the science and practice of time-lapse cytometry, PHI is actively expanding its customer base and scientific collaborations in cancer research, inflammatory and autoimmune diseases, stem cell biology, gene therapy, regenerative medicine and toxicological studies.

Subscribe

Media

Media

Documents & Links